← All stocks

TANDEM DIABETES CARE INC

TNDM No buying or selling
CIK 0001438133 #2225 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

17 insiders · 0 transactions
4.6×

John Sheridan holds only 4.6 times base salary in stock. $3.69M of shares against $790.58K in salary for 2025.

Salary from the company's own proxy. The shares are what John Sheridan last reported holding, valued at $23.05, the price Common Stock was last bought or sold at on the open market here, on 17 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BLICKENSTAFF KIM D
Director
165,190
$3.81M
−19.5%
Sheridan John F
PRESIDENT & CEO
160,260
$3.69M
+222.0%
Vosseller Leigh
EVP & CHIEF FINANCIAL OFFICER
77,620
$1.79M
+142.1%
Morrison Susan
EVP & Chief Admin. Officer
52,788
$1.22M
+125.9%
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
40,317
$929.31K
Gasser Elizabeth Anne
EVP, Chief Strategy Officer
34,505
$795.34K
+162.9%
Carpenter Rick
EVP & Chief Technology Officer
32,148
$741.01K
+151.1%
Hansen Shannon Marie
EVP & Chief Legal Officer
31,650
$729.53K
+227.0%
Kyrillos Jean-Claude
EVP & Chief Operating Officer
30,290
$698.18K
Howell Peyton R
Director
29,836
$687.72K
+78.8%
Allen Dick
Chair Emeritus
28,146
$648.77K
+75.9%
McGroddy-Goetz Kathleen
Director
26,612
$613.41K
+97.6%
TWOMEY CHRISTOPHER J
Director
24,434
$563.20K
+116.5%
Sodhi Rajwant
Director
24,280
$559.65K
+118.1%
ROBERTSON REBECCA B
Director
22,542
$519.59K
+139.9%
Malagueira Joao Paulo Falcao
Director
22,458
$517.66K
+196.9%
Cha Myoungil
Director
22,458
$517.66K
+196.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 16 Nov 2016